- Home
- PWR vs GEHC Comparison
PWR vs GEHC Comparison
Compare PWR & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PWR
- GEHC
- Stock Information
- Founded
- PWR 1997
- GEHC 1892
- Country
- PWR United States
- GEHC United States
- Employees
- PWR N/A
- GEHC N/A
- Industry
- PWR Engineering & Construction
- GEHC Computer Software: Prepackaged Software
- Sector
- PWR Industrials
- GEHC Technology
- Exchange
- PWR Nasdaq
- GEHC Nasdaq
- Market Cap
- PWR 55.4B
- GEHC 34.8B
- IPO Year
- PWR 1998
- GEHC N/A
- Fundamental
- Price
- PWR $386.90
- GEHC $74.45
- Analyst Decision
- PWR Buy
- GEHC Strong Buy
- Analyst Count
- PWR 22
- GEHC 10
- Target Price
- PWR $345.00
- GEHC $89.10
- AVG Volume (30 Days)
- PWR 1.1M
- GEHC 3.7M
- Earning Date
- PWR 07-31-2025
- GEHC 07-30-2025
- Dividend Yield
- PWR 0.10%
- GEHC 0.19%
- EPS Growth
- PWR 20.31
- GEHC 38.77
- EPS
- PWR 6.19
- GEHC 4.76
- Revenue
- PWR $24,874,310,000.00
- GEHC $19,799,000,000.00
- Revenue This Year
- PWR $15.25
- GEHC $5.19
- Revenue Next Year
- PWR $9.42
- GEHC $4.71
- P/E Ratio
- PWR $62.48
- GEHC $15.64
- Revenue Growth
- PWR 15.77
- GEHC 1.56
- 52 Week Low
- PWR $227.08
- GEHC $57.65
- 52 Week High
- PWR $389.21
- GEHC $94.80
- Technical
- Relative Strength Index (RSI)
- PWR 66.98
- GEHC 53.10
- Support Level
- PWR $371.48
- GEHC $74.38
- Resistance Level
- PWR $383.28
- GEHC $77.32
- Average True Range (ATR)
- PWR 8.79
- GEHC 1.57
- MACD
- PWR -0.61
- GEHC -0.01
- Stochastic Oscillator
- PWR 90.69
- GEHC 53.86
About PWR Quanta Services Inc.
Quanta Services is a leading provider of specialty contracting services, delivering comprehensive infrastructure solutions for the electric and gas utility, communications, pipeline, and energy industries in the United States, Canada, and Australia. Quanta reports its results under two segments: electric infrastructure and underground utility and infrastructure.
About GEHC GE HealthCare Technologies Inc.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).